Loading interface...

Eltocin 125 MG Tablet DT

Manufactured byIpca Laboratories Pvt. Ltd.
ContainsErythromycin
Description

Eltocin 125 MG Tablet DT is a macrolide antibiotic which is used to treat infections of the lungs, throat, ear, etc. caused by bacteria. This medicine is not recommended for use in case of a common cold, flu, or other viral infections since it is active against infections caused by bacteria only.

Side effects

Major & minor side effects for Eltocin 125 MG Tablet DT

  • Skin blistering
  • Chills
  • Diarrhea
  • Fast heartbeat
  • Skin rash
  • Muscle or joint pain
  • Chest tightness
  • Abdominal pain
  • Loss of appetite
  • Weight loss
  • Dizziness

Uses of Eltocin 125 MG Tablet DT

What is it prescribed for?

  • Pneumonia
  • Ear Infection (Otitis Media)
  • Bronchitis
  • Pertussis
  • Prophylaxis for Rheumatic Fever
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The peak effect of this medicine can be observed within 3 to 4 hours of administration of the dose.
  • How long do the effects of this medicine last?
    The effect of this medicine lasts for an average duration of 4 to 6 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. If the medicine is used, the infant should be monitored closely for any undesired side effects.

Allergy

This medicine is not recommended for use in patients with a known allergy to erythromycin, any other macrolides, or any other inactive ingredients present along with it.

Hepatic impairment

This medicine is not recommended for use in patients with a known history of cholestatic jaundice or hepatic impairment caused by the prior use of this medicine. It is also not recommended for use in patients with a history of severe hepatic impairment due to the increased risk of serious adverse effects.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. If the medicine is used, the infant should be monitored closely for any undesired side effects.
General warnings

Drug-resistance

Usage of this medicine without sufficient proof or suspicion of a bacterial infection should be avoided. Irrational dosing might fail in providing the benefits and even cause toxicity. It may also increase the risk of development of bacteria that are drug resistant.

Clostridium difficile-associated Diarrhea

Antibiotic therapy will cause an imbalance in the normal microbial flora of the large intestine, which may promote the growth of a bacteria called Clostridium difficile and you may experience severe diarrhea as a result. Report any such incidence to the doctor on priority and avoid usage of this medicine in such cases.

Impaired liver function

This medicine should be used with caution in patients with a known history of an impaired liver function due to the increased risk of severe adverse effects. Close monitoring of liver function, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

QT prolongation

This medicine should be used with caution in patients with a known history of arrhythmias, heart diseases, and patients who are on medicines that prolong QT intervals such as psychiatric drugs and anti-arrhythmic drugs due to the increased risk of worsening of the patient's condition. Replacement with a suitable alternative should be considered based on the clinical condition of the patient.

Myasthenia Gravis

This medicine should be used with caution in patients with a history of myasthenia gravis due to the increased risk of worsening of the patient's condition. Any unusual symptoms should be reported to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative should be considered based on the clinical condition of the patient.

Missed Dose

The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it is already time for your next scheduled dose. Do not use extra medicine to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Clonazepam

Quetiapine

Amiodarone

Pimozide

Ethinyl Estradiol

Verapamil

Disease interactions

Impaired liver function

This medicine should be used with caution in patients with a known history of liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

QT Prolongation

This medicine should be used with extreme caution in patients with a known history of arrhythmias, heart diseases, and patients who are on medicines that prolong QT intervals such as psychiatric drugs and anti-arrhythmic drugs. This medicine may further prolong QT intervals in such patients and worsen the patient's condition. Replacement with a suitable alternative should be considered based on the clinical condition.

Myasthenia Gravis

This medicine should be used with caution in patients with a known history of myasthenia gravis due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative should be considered based on the clinical condition of the patient.
Food interactions
Consumption of grapefruit juice is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
Lab interactions
Information not available.
Take this medicine with or without food. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine works by interfering with certain processes that help the bacteria to grow and increase in number.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Macrolides

Schedule

Schedule H

Erythromycin: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 31 March 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a682381.html

DailyMed - Erythromycin stearate tablet, film coated [Internet]. Dailymed.nlm.nih.gov. 2018 [cited 22 June 2018]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6c789378-0ec7-4874-aa42-e3418e859f86

Erythrocin 250 Tablets - Summary of Product Characteristics (SmPC) - (eMC) [Internet]. Medicines.org.uk. 2018 [cited 22 June 2018]. Available from:

https://www.medicines.org.uk/emc/product/403/smpc

Erythromycin - DrugBank [Internet]. Drugbank.ca. 2018 [cited 25 June 2018]. Available from:

https://www.drugbank.ca/drugs/DB00199
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 26 Jun 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.